FDA Drug Moderate Class II Completed

Tizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA, NDC 55111-180-15

Reported: January 17, 2024 Initiated: January 2, 2024 #D-0223-2024

Product Description

Reason for Recall

Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.

Details

Recalling Firm: Dr. Reddy's Laboratories, Inc.
Units Affected: 38,952 bottles
Distribution: USA Nationwide
Location: Princeton, NJ

Frequently Asked Questions

What product was recalled? ▼

Tizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA, NDC 55111-180-15. Recalled by Dr. Reddy's Laboratories, Inc.. Units affected: 38,952 bottles.

Why was this product recalled? ▼

Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.

Which agency issued this recall? ▼

This recall was issued by the FDA Drug on January 17, 2024. Severity: Moderate. Recall number: D-0223-2024.

Related Recalls

FDA Drug Moderate

Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: U…

Unichem Pharmaceuticals USA Inc. · 2026-02-11

FDA Drug Critical

Green Lumber Natural Fuel For Men capsule, packaged in 2, 4, 10, and 30-count blister packs. GreenLumber.com, 2618 San…

Green Lumber Holdings, LLC · 2026-02-11

FDA Drug Moderate

Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500…

Granules Pharmaceuticals Inc. · 2026-02-11

FDA Drug Critical

Diclofenac Sodium, Topical Gel, 3%, 100 g, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1…

SUN PHARMACEUTICAL INDUSTRIES INC · 2026-02-11

FDA Drug Critical

Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313

HANDELNINE GLOBAL LLC · 2026-02-11

Explore Related Data

Vehicle Safety → Drug Information →